Pathway Choice Focus (NY) 4-Year review

Yes, for the right buyer — which in this case means a New York resident looking for a short-term guaranteed rate. The absence of a market value adjustment is a genuine positive in a rising-rate environment, since surrender values are not adjusted downward if rates move up during the term. For that specific buyer, this is a clean, well-structured MYGA. For anyone outside New York, it is not available at all, which ends the conversation.

The main reason to consider Pathway Choice Focus (NY) is simplicity and certainty. You put money in, it earns a fixed rate for four years, and you get the full contract value back at the end without any MVA exposure. The secondary reason is the waiver provisions — extended care and terminal illness waivers give some practical liquidity access in circumstances that genuinely matter. For a short-term MYGA buyer in New York who has experienced a product with MVA risk before, the no-MVA design is worth paying attention to.

I think this product is best for New York residents in their late 50s to mid-70s who want to park a portion of retirement savings in a 4-year fixed commitment — roughly the time frame before Social Security claiming, a pension start, or a known liquidity event. It suits buyers who prefer the CD-like clarity of a guaranteed rate over the variable crediting mechanics of a fixed indexed annuity. It is not a fit for anyone outside New York, anyone who wants income rider features, or anyone who needs access to principal above the 10% free-withdrawal amount in a given year.

You are buying a contractual guarantee from The United States Life Insurance Company in the City of New York (rated A by A.M. Best) that your money will earn a fixed rate for four years. There are no index strategies, no caps or participation rates to track, no separate fee-based riders to evaluate. The rate is set at issue and does not change during the initial period. After the four-year term, the contract renews at a newly declared rate — never below the contract minimum — or you can take the money without penalty. The death benefit passes the full contract value to beneficiaries without surrender charges and bypasses probate, which is a real practical benefit for estate-planning-minded buyers.

At issue, Corebridge declares a fixed interest rate for the full 4-year term. That rate depends on the premium tier: as of the most recent available rates (April 2026), the low band (under $100,000) was set at 3.35%, the mid band ($100,000–$249,999) at 4.15%, and the high band ($250,000 or more) at 4.20%. Rates effective May 2026 moved slightly higher: 3.45%, 4.25%, and 4.30% respectively. Interest credits daily from the effective date. After the initial 4-year period, the carrier declares a renewal rate annually; the contract specifies a minimum guaranteed annual return range of 0.15%–3.00% depending on when the contract was issued and how rates are set in the contract document.

The rate banding structure matters more here than it does with some competitors. The gap between the low band and mid band is roughly 0.80 percentage points, which on a $50,000 premium over four years is a noticeable difference in terminal value. Buyers near the $100,000 threshold who can reach that level should seriously weigh doing so.

The most meaningful secondary feature is the no-MVA design. A market value adjustment — common in many MYGAs — means that if you surrender during the charge period, your penalty is not fixed at the stated percentage; it adjusts based on interest rate movements, which can make it larger in a rising-rate environment. This product carries no MVA, so the surrender charge is exactly what the schedule says it is: 7% in year one, stepping down to 4% in year four. That transparency is valuable for a buyer who is uncertain about their actual timeline and wants to know the worst-case cost of an early exit.

The extended care waiver is also worth noting. After the second contract year, if the owner requires 90 or more consecutive days of extended care, surrender charges are waived — up to the owner reaching age 86. That kind of provision adds real practical value for buyers who are older or have health considerations.

The 4-year surrender period is a genuine commitment, not a suggestion. Outside the free-withdrawal provision, exits before the end of year four will cost you: 7% in year one, 6% in year two, 5% in year three, and 4% in year four. There is no MVA on top of that, which at least makes the math straightforward. The free-withdrawal provision allows up to 10% of the previous anniversary contract value after the first contract year, and multiple withdrawals in a single year are permitted as long as the $2,000 minimum contract balance is maintained.

RMD treatment is clean: distributions required under IRS RMD rules are permitted at any time after contract issue without surrender charges. For qualified money, that removes one of the practical friction points a MYGA can create.

An optional return-of-premium guarantee is available at purchase, though it reduces the initial credited rate. Buyers who want an absolute floor on what they can recover should ask about this option and evaluate whether the rate reduction is worth the additional protection.

There are no annual contract fees, no initial sales charges, and no mortality and expense charges. The only cost friction is the surrender charge schedule above, which is visible and fixed. That is a cleaner fee structure than many annuities at this duration.

The structural tradeoffs are straightforward. First, the locked rate is fixed — if market rates move up significantly during the 4-year term, you do not benefit. Second, the rate banding means buyers under $100,000 are accepting a materially lower return than the headline rate implies. Third, the product is New York only, which means there is no ability to compare it against the non-NY version of the same product on rate.

Legal Entity: The United States Life Insurance Company in the City of New York

Parent: Corebridge Financial, Inc.

A.M. Best Rating: A